Call Start: 16:30 January 1, 0000 5:20 PM ET Revance Therapeutics, Inc. (NASDAQ:RVNC) Q2 2022 Earnings Conference Call August 9, 2022 16:30 ET Company Participants Jessica Serra - Head of Investor Relations & ESG Mark Foley - Chief Executive Officer Dustin Sjuts - President Tobin Schilke - Chief Financial Officer & Principal Accounting Officer Conference Call Participants Seamus Fernandez - Guggenheim Partners Ken Cacciatore - Cowen Annabel Samimy - Stifel David Amsellem - Piper Sandler Tim Lugo - William B ...